FDA, Salix Seek Answers on Testing Antibiotic to Treat IBS
By Mari Serebrov
Tuesday, November 15, 2011
Both the FDA and Salix Pharmaceuticals Inc. will be looking to members of the Gastrointestinal Drugs Advisory Committee Wednesday for answers on designing a clinical trial to demonstrate the safety and efficacy of an antibiotic intended to be used intermittently to treat a chronic condition.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.